{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:04Z","timestamp":1791389044182,"version":"4.3.3"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Advanced liver disease with massive liver damage may affect the metabolism of hypoglycemic agents and increase the risk of hypoglycemia. We conduct this research to compare the risk of severe hypoglycemia between patients with type 2 diabetes, with and without compensated liver cirrhosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From Taiwan\u2019s National Health Insurance Research Database, we identified persons with type 2 diabetes with cirrhosis (<jats:italic>n<\/jats:italic> = 18,209) and without cirrhosis (<jats:italic>n<\/jats:italic> = 538,510) from January 1, 2000, to December 31, 2010. Cox proportional hazards models were adopted to assess risks of all-cause mortality and severe hypoglycemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean follow-up period of this study was 3.7 years. The incidence rates of death during follow-up were 26.54 and 2.75 per 1,000 patient-years [aHR 7.63 (6.70\u20138.70)] for patients with cirrhosis and without cirrhosis, respectively. The incidence rates of severe hypoglycemia during follow-up were 0.53 and 0.14 per 1,000 patient-years [aHR 2.74 (1.52\u20134.92)] for patients with and without cirrhosis, respectively. The subgroup analysis of hypoglycemia risks in patients with and without cirrhosis disclosed no significant interaction for variables such as age, sex, chronic kidney disease, sulfonylurea use, number of oral antidiabetic drugs, insulin, b-blocker, and fibrate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This cohort study demonstrated that patients with type 2 diabetes and compensated cirrhosis showed a higher risk of mortality and severe hypoglycemia than those without liver cirrhosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.962337","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T13:47:16Z","timestamp":1672840036000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes"],"prefix":"10.3389","volume":"9","author":[{"given":"Fu-Shun","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Sin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chii-Min","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/15733998113099990059","article-title":"The science of hypoglycemia in patients with diabetes.","volume":"9","author":"Oyer","year":"2013","journal-title":"Curr Diabetes Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","article-title":"Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.","volume":"7","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B3","first-page":"37","author":"Cryer","year":"2012","journal-title":"Hypoglycemia in Diabetes: Pathophysiology, Prevalence and Prevention."},{"key":"B4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1463-1326.2004.00421.x","article-title":"Hypoglycaemia and cognitive function.","volume":"7","author":"Warren","year":"2005","journal-title":"Diabetes Obes Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0889-8529(18)30389-X","article-title":"Hypoglycemia associated with liver disease and ethanol.","volume":"18","author":"Arky","year":"1989","journal-title":"Endocrinol Metab Clin North Am."},{"key":"B6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care."},{"key":"B7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"World J Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4103\/ijem.IJEM_512_16","article-title":"Consensus statement on dose modifications of antidiabetic agents in patients with hepatic impairment.","volume":"21","author":"Gangopadhyay","year":"2007","journal-title":"Indian J Endocrinol Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","article-title":"Taiwan\u2019s new national health insurance program: genesis and experience so far.","volume":"22","author":"Cheng","year":"2003","journal-title":"Health Aff."},{"key":"B10","first-page":"157","article-title":"Accuracy of diabetes diagnosis in health insurance claims data in Taiwan.","volume":"104","author":"Lin","year":"2005","journal-title":"J Formos Med Assoc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1097\/MCG.0b013e3182688d2f","article-title":"Use of administrative claims data for identifying patients with cirrhosis.","volume":"47","author":"Nehra","year":"2013","journal-title":"J Clin Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/318627","article-title":"Improving survival in decompensated cirrhosis.","volume":"2012","author":"Mukerji","year":"2012","journal-title":"Int J Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s11606-007-0310-5","article-title":"Chronic illness with complexity: implications for performance measurement of optimal glycemic control.","volume":"22","author":"Meduru","year":"2007","journal-title":"J Gen Intern Med."},{"key":"B14","first-page":"15","article-title":"Diabetes complications severity index and risk of mortality, hospitalization, and health care utilization.","volume":"14","author":"Young","year":"2008","journal-title":"Am J Manag Care."},{"key":"B15","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.","volume":"17","author":"D\u2019Agostino","year":"1998","journal-title":"Stat Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data.","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1478-3231.2011.02517.x","article-title":"All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study.","volume":"32","author":"Fleming","year":"2012","journal-title":"Liver Int."},{"key":"B18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1665-2681(19)31588-1","article-title":"The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study.","volume":"10","author":"Quintana","year":"2011","journal-title":"Ann Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1464-5491.2007.02341.x","article-title":"Hypoglycaemia in type 2 diabetes.","volume":"25","author":"Amiel","year":"2008","journal-title":"Diabetic Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1517\/14740338.2012.694424","article-title":"Drug-induced hypoglycaemia in type 2 diabetes.","volume":"11","author":"Inkster","year":"2012","journal-title":"Expert Opin Drug Saf."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.2337\/diacare.26.4.1176","article-title":"DARTS\/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes.","volume":"26","author":"Leese","year":"2003","journal-title":"Diabetes Care."},{"key":"B22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0016-5085(19)34237-4","article-title":"Fulminating hepatitis with recurrent hypoglycemia and hemorrhage.","volume":"53","author":"Samson","year":"1967","journal-title":"Gastroenterology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJM197012242832604","article-title":"Glucose homeostasis in viral hepatitis.","volume":"283","author":"Felig","year":"1970","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000343458","article-title":"Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus.","volume":"87","author":"Gundling","year":"2013","journal-title":"Digestion."},{"key":"B25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/bmj.2.5759.416-a","article-title":"Hepatic hypoglycaemia.","volume":"2","year":"1971","journal-title":"Br Med J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/gut.15.11.907","article-title":"A study of carbohydrate metabolism in postnecrotic cirrhosis liver.","volume":"15","author":"Yeung","year":"1974","journal-title":"Gut."},{"key":"B27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1517\/17425255.2014.902444","article-title":"Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.","volume":"10","author":"Scheen","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.962337\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T13:47:23Z","timestamp":1672840043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.962337\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":27,"alternative-id":["10.3389\/fmed.2022.962337"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.962337","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"962337"}}